Cumulative lipid–inflammatory indices and the risk of cardiometabolic multimorbidity: a prospective cohort study
Frontiers in Endocrinology · 10.08.2026 · 17
DOI: 10.3389/fendo.2026.1909025 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Endocrinology, online erschienen am 10.08.2026. Verfasst von Lijun Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Lipids, Inflammation, Cardiovascular Diseases, Diabetes Mellitus, Type 2. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cardiometabolic multimorbidity (CMM) has become a major global public health challenge. Although dyslipidemia and chronic low-grade inflammation are known to contribute to cardiometabolic diseases, their long-term cumulative combined effects on the risk of CMM remain poorly understood. This study aimed to evaluate the associations of cumulative lipid-inflammatory indices with incident CMM in a large prospective cohort.
Methods
A total of 25,376 participants from the Kailuan cohort were included and followed up until December 31, 2023. Nine cumulative lipid-inflammatory exposure indices were constructed via trapezoidal area-under-the-curve calculation using repeated measurements from 2006 to 2010. The primary outcome was incident CMM, defined as the concurrence of at least two cardiometabolic diseases including type 2 diabetes, ischemic heart disease and stroke. Multivariable Cox regression, restricted cubic spline analyses, competing-risk models, and subgroup analyses were applied.
Results
During a median follow-up of 13.0 years, 481 incident CMM events were documented. All nine cumulative lipid-inflammatory indices were independently and positively associated with an elevated risk of CMM in a dose-response manner. Incorporating these indices into conventional risk model improved risk reclassification and discriminatory ability.
Conclusions
Elevated cumulative lipid-inflammatory indices are associated with a higher risk of incident CMM. These composite markers may serve as auxiliary indicators for preliminary risk stratification, while causal relationships cannot be confirmed based on this observational cohort alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School, Hebei Medical University, Shijiazhuang, Hebei, China.
- Department of Cardiology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei, China.
- Department of Cardiology, Tangshan Gongren Hospital, Tangshan, Hebei, China.
- Department of Cardiology, Kailuan General Hospital, Tangshan, Hebei, China.
- The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Zitieren
APA
Meng, L., Gao, H., Yang, J., Wu, S., Chen, S., Wu, Y., & Zhang, Q. (2026). Cumulative lipid–inflammatory indices and the risk of cardiometabolic multimorbidity: a prospective cohort study. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1909025
Vancouver
Meng L, Gao H, Yang J, Wu S, Chen S, Wu Y, et al. Cumulative lipid–inflammatory indices and the risk of cardiometabolic multimorbidity: a prospective cohort study. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1909025
BibTeX
@article{Meng2026,
author = {Meng, Lijun and Gao, Haibo and Yang, Jing and Wu, Shouling and Chen, Shuohua and Wu, Yuntao and Zhang, Qi},
title = {Cumulative lipid–inflammatory indices and the risk of cardiometabolic multimorbidity: a prospective cohort study},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
doi = {10.3389/fendo.2026.1909025}
}
EUVIMED